Feedback
Settings

Settings

Goto Application

1. WO2006124451 - ANTI-IL-13 ANTIBODIES, COMPOSITIONS, METHODS AND USES

PermaLink
Publication Number WO/2006/124451
Publication Date 23.11.2006
International Application No. PCT/US2006/018069
International Filing Date 10.05.2006
IPC
C07K 16/00 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
C07K 14/00 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A61K 39/395 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
C12N 15/00 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
C12N 15/85 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09Recombinant DNA-technology
63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
79Vectors or expression systems specially adapted for eukaryotic hosts
85for animal cells
CPC
A61P 43/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
C07K 16/244
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
24against cytokines, lymphokines or interferons
244Interleukins [IL]
C07K 2317/21
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
2317Immunoglobulins specific features
20characterized by taxonomic origin
21from primates, e.g. man
C07K 2317/55
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
2317Immunoglobulins specific features
50characterized by immunoglobulin fragments
55Fab or Fab'
C07K 2317/76
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
2317Immunoglobulins specific features
70characterized by effect upon binding to a cell or to an antigen
76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
C07K 2317/92
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
2317Immunoglobulins specific features
90characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Applicants
  • CENTOCOR, INC. [US]/[US] (AllExceptUS)
  • HEAVNER, George, A. [US]/[US] (UsOnly)
  • NASO, Michael, S. [US]/[US] (UsOnly)
  • O'NEIL, Karyn, T. [US]/[US] (UsOnly)
  • RAUCHENBERGER, Robert [DE]/[DE] (UsOnly)
  • SWEET, Raymond [US]/[US] (UsOnly)
  • LI, Li [CA]/[US] (UsOnly)
Inventors
  • HEAVNER, George, A.
  • NASO, Michael, S.
  • O'NEIL, Karyn, T.
  • RAUCHENBERGER, Robert
  • SWEET, Raymond
  • LI, Li
Agents
  • JOHNSON, Philip, S.
Priority Data
60/679,92511.05.2005US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ANTI-IL-13 ANTIBODIES, COMPOSITIONS, METHODS AND USES
(FR) ANTICORPS ANTI-IL-13, COMPOSITIONS, PROCEDES ET UTILISATIONS
Abstract
(EN)
The present invention relates to at least one novel anti-IL-13 antibody, including isolated nucleic acids that encode at least one anti-IL-13 antibody, IL-13, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
(FR)
La présente invention concerne au moins un nouvel anticorps anti-IL-13, ainsi que des acides nucléiques isolés qui codent au moins un anticorps anti-IL-13, de l'IL-13, des vecteurs, des cellules hôtes, des animaux ou végétaux transgéniques, et des procédés de fabrication et d'utilisation correspondants, y-compris des compositions, procédés et dispositifs thérapeutiques.
Also published as
EP6759485
US20080044420
Latest bibliographic data on file with the International Bureau
# -